Literature DB >> 15190212

Does cancer solve an optimization problem?

Natalia Komarova1.   

Abstract

Many cancers are characterized by a high degree of aneuploidy, which is believed to be a result of chromosomal instability (CIN). The precise role of CIN in cancer is still the matter of a heated debate. We present a quantitative framework for examining the selection pressures acting on populations of cells and weigh the "pluses" and "minuses" of CIN from the point of view of a selfish cell. We calculate the optimal rate of chromosome loss assuming that cancer is initiated by inactivation of a tumor suppressor gene followed by a clonal expansion. The resulting rate, p* = 10(-2)per cell division per chromosome, is similar to that obtained experimentally by Lengauer et al. (1997). Our analysis further suggests that CIN does not arise simply because it allows a faster accumulation of carcinogenic mutations. Instead, CIN must arise because of alternative reasons, such as environmental factors, epigenetic events, or as a direct consequence of a tumor suppressor gene inactivation. The increased variability alone is not a sufficient explanation for the presence of CIN in the majority of cancers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190212

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  3 in total

Review 1.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

2.  Fastest time to cancer by loss of tumor suppressor genes.

Authors:  Cynthia Sanchez-Tapia; Frederic Y M Wan
Journal:  Bull Math Biol       Date:  2014-10-23       Impact factor: 1.758

3.  Selective pressures for and against genetic instability in cancer: a time-dependent problem.

Authors:  Natalia L Komarova; Alexander V Sadovsky; Frederic Y M Wan
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.